Premium
Sedative polypharmacy mediates the effect of mechanical ventilation on delirium in critically ill COVID ‐19 patients: A retrospective cohort study
Author(s) -
Bose Somnath,
Kelly Lauren,
Shahn Zachary,
Novack Lena,
BannerGoodspeed Valerie,
Subramaniam Balachundhar
Publication year - 2022
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/aas.14119
Subject(s) - delirium , mechanical ventilation , medicine , polypharmacy , retrospective cohort study , confounding , sedative , anesthesia , intensive care medicine , emergency medicine
Background Polypharmacy of sedatives (PP) is a potentially modifiable, iatrogenic risk factor for ICU delirium. The extent to which sedative PP influenced development of high rates of delirium among critically ill COVID‐19 patients is unknown. We tested the hypothesis that PP, defined as the use of four or more classes of intravenous agents, is a mediator in the causal pathway of mechanical ventilation and delirium. Methods Retrospective cohort study of adults admitted with a primary diagnosis of RT‐PCR+ for SARS‐CoV2 to ICUs of a tertiary‐level academic medical center between February 2020 and April 2021. Mediation analysis was conducted with bootstrap estimation to assess whether an association between mechanical ventilation and delirium was mediated by PP. Analyses were adjusted for potential confounders related to mechanical ventilation, mediator, and outcome, including age, gender, vasopressor use, median RASS scores, SOFA score within 24 h of admission, and maximum CRP levels. Results A total of 212 patients were included in the analysis. Of total patients, 72.6%(154/212) of patients had delirium (CAM‐ICU+) during ICU stay. 54.7%(116/212) patients received PP. Mechanical ventilation (OR 3.81 [1.16–12.52]) and PP (OR 7.38 [2.4–22.68]) were identified as risk factors for development of ICU delirium after adjusting for prespecified confounders. PP acts as a mediator in the causal pathway between mechanical ventilation and delirium. 39% (95% CI: 17%–94%) of the effect of mechanical ventilation on delirium was mediated through PP. Conclusion PP mediates approximately 39% of the effect of mechanical ventilation on delirium, which is clinically and statistically significant. Studies should assess whether mitigating PP could lead to reduction in ICU delirium. Implication Statement PP of sedatives (defined as use of four or more intravenous agents) mediates approximately 39% of the effect of mechanical ventilation on development of ICU delirium. Avoidance of sedative PP may represent a viable strategy for reduction of ICU delirium.